One stage atrioventricular nodal ablation and leadless pacemaker implantation for refractory atrial fibrillation.
Chu Pak LauKathy Lai-Fun LeePublished in: Journal of arrhythmia (2018)
Atrioventricular nodal (AVN) ablation and right ventricular (RV) pacing is recommended for refractory atrial fibrillation (AF) and tachycardia-bradycardia syndrome. Three AF patients (mean age 83, range 79-89 years) underwent AVN ablation and transvenous leadless pacemaker Micra™ implantations using the same venous access without anticoagulation interruption. Satisfactory pacing 0.59 (0.50-0.63) V at 0.24 ms and sensing 11.2 (6.3-15.6) mV were achieved within 1-3 deployments. There were no vascular complications nor device dislodgment. Durable pacemaker parameters and VVIR pacing were achieved. Combined AVN ablation and leadless pacemaker implantation is feasible and safe, and avoids pacemaker pocket hematoma and bleeding complications in patients on uninterrupted anticoagulation.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- end stage renal disease
- newly diagnosed
- heart failure
- ejection fraction
- vena cava
- percutaneous coronary intervention
- multiple sclerosis
- lymph node
- prognostic factors
- peritoneal dialysis
- venous thromboembolism
- patient reported outcomes
- pulmonary embolism
- case report
- neoadjuvant chemotherapy
- radiation therapy
- coronary artery disease
- mitral valve
- left ventricular